← Open Payments lookup

DEBORAH MOORE: Open Payments

NPI 1942353180 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,909 in 86 payments from 12 companies in 2025. Trend: 2023 $1,794 · 2024 $1,309 · 2025 $1,909

Food & beverage: $1,909
CompanyPaymentsAmount
ABBVIE INC.33$527
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$359
Vanda Pharmaceuticals Inc.6$206
Axsome Therapeutics, Inc.10$198
Otsuka America Pharmaceutical, Inc.8$172
Gilead Sciences, Inc.1$129
Takeda Pharmaceuticals U.S.A., Inc.5$101
Alkermes, Inc.3$70
Teva Pharmaceuticals USA, Inc.2$53
Almatica Pharma LLC2$49

Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, Auvelity, Yeztugo, TRINTELLIX, ARISTADA.

Industry payments across CA — which companies pay providers there.